Although MYC translocation does not occur frequently in MCL, the overexpression and upregulation of MYC targets are associated with aggressiveness and therapeutic resistance, including BTKi-resistance [11, 12] and CAR-T resistance (this study). Here, MYC is linked to mantle cell lymphoma.